Literature DB >> 206646

The effect of helper virus on Abelson virus-induced transformation of lymphoid cells.

N Rosenberg, D Baltimore.   

Abstract

Abelson murine leukemia virus (A-MuLV)-transformed fibroblast nonproducer cells were used to prepare A-MuLV stocks containing a number of different helper viruses. The oncogenicity of the A-MuLV stocks was tested by animal inoculation and their ability to transform normal mouse bone marrow cells was measured in vitro. All of the A-MuLV stocks transformed fibroblast cells efficiently. However, only A-MuLV stocks prepared with helper viruses that are highly oncogenic were efficient in vivo and in vitro in hematopoietic cell transformation. In addition, inefficient helpers did not establish a stable infection in lymphoid nonproducer cells. Thus, helper virus has a more central role in lymphoid cell transformation than in fibroblast cell transformation.

Entities:  

Mesh:

Year:  1978        PMID: 206646      PMCID: PMC2184241          DOI: 10.1084/jem.147.4.1126

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Effect of the Fv-1 locus on the titration of murine leukemia viruses.

Authors:  P Jolicoeur; D Baltimore
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses.

Authors:  P K Vogt
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Lymphosarcoma: virus-induced thymic-independent disease in mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

6.  Specialized DNA polymerases in lymphoid cells.

Authors:  D Baltimore; A E Silverstone; P C Kung; T A Harrison; R P McCaffrey
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Biological and serological characterization of radiation leukemia virus.

Authors:  A Declève; M Lieberman; J N Ihle; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

9.  Induction of lymphoma and associated xenotropic type C virus in C57L mice by whole-body irradiation.

Authors:  P Arnstein; J L Riggs; L S Oshiro; R J Huebner; E H Lennette
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

10.  Effect of pseudotype on Abelson virus and Kirsten sarcoma virus-induced leukemia.

Authors:  C D Scher
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  52 in total

1.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

Authors:  N Hattori; F Michaels; K Fargnoli; L Marcon; R C Gallo; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Moloney leukemia virus immortalizes B lymphocytes in vitro.

Authors:  J Runnels; L Serunian; M Thursby; N Rosenberg
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.

Authors:  O N Witte; N Rosenberg; M Paskind; A Shields; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints.

Authors:  M R Lieber; J E Hesse; K Mizuuchi; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Role of recombinant ecotropic and polytropic viruses in the development of spontaneous thymic lymphomas in HRS/J mice.

Authors:  C Y Thomas; R Khiroya; R S Schwartz; J M Coffin
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.

Authors:  O N Witte; S Goff; N Rosenberg; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

9.  BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.

Authors:  S S Clark; E Chen; M Fizzotti; O N Witte; V Malkovska
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.

Authors:  R Risser
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.